Merck defends antibiotic`s approval from 2019
17 May 2023 //
ENDPTS
FDA approvals roundup: Recarbrio
10 Jun 2020 //
RAPS
US FDA approves Recarbrio to treat hospital-acquired bacterial pneumonia
07 Jun 2020 //
PHARMABIZ
FDA Approves Merck’s (imipenem, cilastatin, and relebactam) for the Treatment
05 Jun 2020 //
MERCK
Results of Ph 3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™
06 May 2020 //
BUSINESSWIRE
Results of Ph3 Trial Evaluating the Efficacy and Safety of Merck’s RECARBRIO™
05 May 2020 //
BUSINESSWIRE
EMA’s Meeting highlights from CHMP) recommended five medicines for approval
14 Dec 2019 //
EMA